Cargando…
Could tivozanib be a new potent pan-VEGF inhibitor in RCC therapy?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708253/ https://www.ncbi.nlm.nih.gov/pubmed/26816708 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.06.07 |
_version_ | 1782409430827008000 |
---|---|
author | Mihály, Zsuzsanna Panajotu, Alexisz Győrffy, Balázs |
author_facet | Mihály, Zsuzsanna Panajotu, Alexisz Győrffy, Balázs |
author_sort | Mihály, Zsuzsanna |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4708253 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | AME Publishing Company |
record_format | MEDLINE/PubMed |
spelling | pubmed-47082532016-01-26 Could tivozanib be a new potent pan-VEGF inhibitor in RCC therapy? Mihály, Zsuzsanna Panajotu, Alexisz Győrffy, Balázs Transl Androl Urol Research Highlight AME Publishing Company 2012-09 /pmc/articles/PMC4708253/ /pubmed/26816708 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.06.07 Text en 2012 Translational Andrology and Urology. All rights reserved. |
spellingShingle | Research Highlight Mihály, Zsuzsanna Panajotu, Alexisz Győrffy, Balázs Could tivozanib be a new potent pan-VEGF inhibitor in RCC therapy? |
title | Could tivozanib be a new potent pan-VEGF inhibitor in RCC therapy? |
title_full | Could tivozanib be a new potent pan-VEGF inhibitor in RCC therapy? |
title_fullStr | Could tivozanib be a new potent pan-VEGF inhibitor in RCC therapy? |
title_full_unstemmed | Could tivozanib be a new potent pan-VEGF inhibitor in RCC therapy? |
title_short | Could tivozanib be a new potent pan-VEGF inhibitor in RCC therapy? |
title_sort | could tivozanib be a new potent pan-vegf inhibitor in rcc therapy? |
topic | Research Highlight |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4708253/ https://www.ncbi.nlm.nih.gov/pubmed/26816708 http://dx.doi.org/10.3978/j.issn.2223-4683.2012.06.07 |
work_keys_str_mv | AT mihalyzsuzsanna couldtivozanibbeanewpotentpanvegfinhibitorinrcctherapy AT panajotualexisz couldtivozanibbeanewpotentpanvegfinhibitorinrcctherapy AT gyorffybalazs couldtivozanibbeanewpotentpanvegfinhibitorinrcctherapy |